U.S. markets close in 4 hours

Sierra Oncology, Inc. (SRRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.26-0.41 (-2.59%)
As of 11:58AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close15.67
Open15.58
Bid15.25 x 900
Ask15.31 x 1100
Day's Range15.06 - 15.75
52 Week Range8.55 - 16.92
Volume6,876
Avg. Volume27,946
Market Cap168.524M
Beta (5Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-11.91
Earnings DateNov 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • We're Keeping An Eye On Sierra Oncology's (NASDAQ:SRRA) Cash Burn Rate
    Simply Wall St.

    We're Keeping An Eye On Sierra Oncology's (NASDAQ:SRRA) Cash Burn Rate

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

  • Sierra Oncology to Present at H.C. Wainwright 2021 BioConnect Virtual Conference
    PR Newswire

    Sierra Oncology to Present at H.C. Wainwright 2021 BioConnect Virtual Conference

    Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today announced that President and Chief Executive Officer Stephen Dilly, MBBS, PhD, will present an overview of the company at the H.C. Wainwright 2021 BioConnect Virtual Conference taking place January 11-14, 2021.

  • Is SRRA A Good Stock To Buy Now?
    Insider Monkey

    Is SRRA A Good Stock To Buy Now?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 817 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of September 30th, 2020. […]